MENU

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

RLMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days
View a ticker or compare two or three
RLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with XENE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
N/A
XENE - RLMD
48%
Loosely correlated
N/A
SYRE - RLMD
36%
Loosely correlated
N/A
BCYC - RLMD
36%
Loosely correlated
N/A
GRDX - RLMD
36%
Loosely correlated
N/A
RNAC - RLMD
34%
Loosely correlated
N/A
More
Relmada Therapeutics (RLMD) Stocks Price History Chart, Support & Resistance Graph - Tickeron.com